We know that if we watch our patients with moderate mitral regurgitation we are going to have structural changes in miocardial anatomy those will difficult the future surgical treatment. So why we still waiting?
The presence of chronic secondary mitral regurgitation is associated with impaired prognosis. However, in contrast to primary mitral regurgitation, there is currently no evidence that a reduction of secondary mitral regurgitation improves survival. The limited data regarding secondary mitral regurgitation result in a lower level of evidence for treatment recommendations and highlight the importance of decision making by the Heart Team. Heart failure and electrophysiology specialists should be involved.
Functional mitral regurgitation cause by enlargement of the mitral annulus especially moderate ones must have a closely follow up by a heart team to match the optimal time to any intervention and I share Dr. Elmahrouk point of view about survival improvement.
I am agree with both answers and thanks you very much for your time. I think that we must involve herat team in the decision and watch our patients carefully for prevent great morphological changes in heart structure and reduce operation risk. We had learn from aortic patology that delay in surgical indications leads aour patients to worst outcomes, so the question has not been answer yet in moderate functional mitral valve regurgitation.